臨床試驗

Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer

NCT：NCT05804318 · RECRUITING

NCT IDNCT05804318

狀態RECRUITING

開始日期2023-04-13

SponsorVarian, a Siemens Healthineers Company (INDUSTRY)

First posted2023-04-07

Last updated2026-09-09

簡要摘要

This trial is a prospective, single-arm, multi-center clinical trial designed to assess whether adaptive radiotherapy with urethral sparing for low to intermediate risk localized prostate cancer will translate into a decreased rate of patient reported acute urinary side effects, as measured by the patient reported EPIC-26 questionnaire, compared with the historically reported rate for non-adaptive, non-urethral sparing prostate SBRT.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。